Denise Neves Gameiro, Author at Labiotech.eu

About

Journalist intern. Studied Bioengineering in Porto and was a lab rat in Sweden. Enjoying Berlin and the company of Labiotech’s resident plants.

Articles by Denise Neves Gameiro

probiodrug alzheimers mark booth cbo e1458823157506

News and Trends 24 Mar 2016

Leading German Biotech recruits New talent for Fight against Alzheimer’s

Probiodrug (Germany) has hired Mark Booth as Chief Business Officer to propel this Pharma’s global strategy. Among other important roles, Booth was president of Takeda North America. Probiodrug is a Biopharma focused on developing treatments for Alzheimer’s disease. Its strategy is based on the elimination of pyroglutamated Abeta (pGlu), which is one of the way Alzheimer’s […]

March 24, 2016 - 2 minutesmins - By Denise Neves Gameiro

humabs influenza antibody infectious cellclone medimmune

News and Trends 24 Mar 2016

Novel Antibody for Influenza gets FDA Fast-Track Approval

Humabs (Switzerland) has gotten some serious recognition for its antibody platform, as its candidates for Influenza have received FDA fast-track designation. A biologic therapy for Influenza A has been granted Fast Track Designation by the FDA, a ‘programme to accelerate the treatment commercialisation. The therapy is based on an antibody (MEDI8852) that was initially developed by […]

March 24, 2016 - 3 minutesmins - By Denise Neves Gameiro

maat pharma autologous microbiome therapy

News and Trends 23 Mar 2016

French Microbiome Startup Gets €10M to Start Clinical Trials

MaaT Pharma (France) has raised €10M in a series A round, which will allow it to start clinical development of its autologous therapy for imbalance of the Gut Microbiome. MaaT Pharma is developing microbiome-based therapies with an autologous (self-sourced) approach. This means that the patient suffering from dysbiosis is treated with their own microbiome, samples of which were […]

March 23, 2016 - 3 minutesmins - By Denise Neves Gameiro

evotec topas therapeutics autoimmune nanotechnology

News and Trends 23 Mar 2016

Leading German Biotech Spins Off a New Startup in Autoimmune Diseases

Evotec (Germany) has launched a spin-off, Topas Therapeutics, to create nanoparticle-based therapeutics to treat immunological disorders. After starting a collaboration for microbiome-related diseases and entering the immuno-oncology field, Evotec is creating a spin-off dedicated to autoimmune diseases. This new biotech, Topas Therapeutics, is based on a technology that induces liver tolerance to specific antigens. This platform could be used to create breakthrough therapies for […]

March 23, 2016 - 2 minutesmins - By Denise Neves Gameiro

metrion drug discovery cardiac risk eurostars

News and Trends 22 Mar 2016

Eurostars grants Metrion €2.2M for Novel Drug Discovery Tests

Metrion Biosciences (UK) is receiving €2.2M in funding for its project to develop phenotypic cardiac safety assays, that could make drug discovery cheaper and faster. Metrion is a Contract Research Organization out of the Babraham Institute in Cambridge (one of the 10 hottest bioincubators in Europe). It provides screening services for drugs still in the discovery […]

March 22, 2016 - 3 minutesmins - By Denise Neves Gameiro

top 5 eastern europe biotech selvita sotio solvo axon asper

News and Trends 22 Mar 2016

5 Cool Biotechs in Eastern Europe

Eastern Europe is home to fascinating culture and rising economies, but how is the Biotech scene developing there? Here are some of the companies that caught our eye. Due to popular demand, we have updated the Labiotech Map to also include Eastern European Biotechs – which we published just last month. We were not sure what we were […]

March 22, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 21 Mar 2016

Ferment the Next Bio-Revolution with IndieBio Accelerator

IndieBio is an accelerator program for new ideas in Synthetic Biology – to transform them into startups during a Summer in Ireland. The potential of Synthetic Biology ranges from biofuels to perfumes to healthcare – and it will be at the forefront of the biotechnological revolution. The concept is already implemented by big Biotechs (with a big presence in France) […]

March 21, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 21 Mar 2016

CAR-T Startup Gets €51M from Top&New Investors

Autolus (UK) has secured over €51M in a recent series B round, led by the biggest Biotech VC in Europe – and a new player in life science investment. Autolus is a 1-year-old spin-off of the University College London (UCL) focusing on the development of next-generation CAR-T therapies, addressing current limitations of this ‘wonder therapy‘. […]

March 21, 2016 - 2 minutesmins - By Denise Neves Gameiro

roche immuno oncology blueprint medicines boston

News and Trends 18 Mar 2016

Roche signs a €900M deal with an Immunotherapy Biotech in Boston

Roche (Switzerland) has picked 5 candidates from Blueprint Medicines (US) to complement its leading oncology pipeline. Roche is a leader in cancer therapies, but its position is threatened by intense competition, not to mention its stakes in the biosimilar war and some bad results from advanced trials. However, it seems that this Big Pharma still […]

March 18, 2016 - 3 minutesmins - By Denise Neves Gameiro

gecko surgical adhesive sofinnova bpifrance

News and Trends 17 Mar 2016

Leading European VC believes this is the “Post-It of Surgery”

Gecko Biomedical (France) has raised €22.5M to get its innovate biopolymers to surgery rooms, and caught the eye of the biggest French Biotech investor, Sofinnova. Gecko has a hot piece of MedTech in its hands: a surgical glue that can stop bleeding from sutured tissues, and in the future could replace stitching altogether. This technology was […]

March 17, 2016 - 3 minutesmins - By Denise Neves Gameiro

gsk miltenyi biotech gmp cell gene therapy tcr car t

News and Trends 17 Mar 2016

GSK partners to Scale Manufacturing of CAR-T Therapies

Production of CAR-T therapies seems to be one of the biggest challenge of this promising technology. Miltenyi Biotec (Germany) and GSK have entered a new partnership to combine the clinical development of cell and gene therapies with manufacturing expertise. Milteniy is a German company of 1600 employees developing products for biomedical research and cellular therapy. It’s not the first […]

March 17, 2016 - 3 minutesmins - By Denise Neves Gameiro

bionic heart patch university tel aviv tau biomaterial nanoelectronics tissue engineering myocardial infarction heart attack nature materials

News and Trends 16 Mar 2016

‘Cyborg’ Heart Patch to Revolutionize Treatment of Heart Attacks

Researchers from Tel Aviv University (Israel) have managed to engineer a Nanotech ‘heart patch’ which could enable remote monitoring and regulation of a patient’s heart – bionic! MedTech continues to blur the boundary between man and machine. A new project combines organic, living tissue and a complex nanoelectronic system to create a bionic heart patch that could help […]

March 16, 2016 - 3 minutesmins - By Denise Neves Gameiro

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Denise Neves Gameiro

About

Articles by Denise Neves Gameiro

Leading German Biotech recruits New talent for Fight against Alzheimer’s

Novel Antibody for Influenza gets FDA Fast-Track Approval

French Microbiome Startup Gets €10M to Start Clinical Trials

Leading German Biotech Spins Off a New Startup in Autoimmune Diseases

Eurostars grants Metrion €2.2M for Novel Drug Discovery Tests

5 Cool Biotechs in Eastern Europe

Ferment the Next Bio-Revolution with IndieBio Accelerator

CAR-T Startup Gets €51M from Top&New Investors

Roche signs a €900M deal with an Immunotherapy Biotech in Boston

Leading European VC believes this is the “Post-It of Surgery”

GSK partners to Scale Manufacturing of CAR-T Therapies

‘Cyborg’ Heart Patch to Revolutionize Treatment of Heart Attacks

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

About

Articles by Denise Neves Gameiro

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!